| 10808027 |
DNA molecules encoding antibodies to tau and methods of making thereof |
Mansuo Lu Hayashi, Jirong Lu, Alberto Alvarado |
2020-10-20 |
$520,171,000 |
| 10011653 |
Antibodies to tau and methods of treatment therewith |
Mansuo Lu Hayashi, Jirong Lu, Alberto Alvarado |
2018-07-03 |
$108,240,000 |
| 9527909 |
Antibodies to tau and uses thereof |
Mansuo Lu Hayashi, Jirong Lu, Alberto Alvarado |
2016-12-27 |
$148,269,000 |
| 9422353 |
Fibroblast growth factor 21 variant, composition , and uses thereof |
Ryan James Darling, Craig Duane Dickinson, Malgorzata Donata Gonciarz |
2016-08-23 |
$470,248,000 |
| 8927492 |
Fibroblast growth factor 21 proteins |
Ryan James Darling, Craig Duane Dickinson, Malgorzata Donata Gonciarz |
2015-01-06 |
$294,405,000 |
| 8883726 |
Fibroblast growth factor 21 variants |
Craig Duane Dickinson, Ryan James Darling, Malgorzata Donata Gonciarz, Radmila Micanovic |
2014-11-11 |
$267,392,000 |
| 8741841 |
Fibroblast growth factor 21 proteins |
Ryan James Darling, Craig Duane Dickinson, Malgorzata Donata Gonciarz |
2014-06-03 |
$121,171,000 |
| 8647864 |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
John Polo, Thomas W. Dubensky, Jr., Ilya Frolov, Jason Gardner, Gillis Otten +1 more |
2014-02-11 |
$13,498,000 |
| 8541369 |
Fibroblast growth factor 21 variants having improved pharmacological potency and/or improved pharmaceutical stability |
Craig Duane Dickinson, Ryan James Darling, Maigorzata Donata Gonciarz, Radmila Micanovic |
2013-09-24 |
$211,871,000 |
| 7977091 |
Eukaryotic layered vector initiation systems |
Thomas W. Dubensky, Jr., John Polo, Carlos Ibanez, Stephen Chang, Douglas J. Jolly +1 more |
2011-07-12 |
$8,981,000 |
| 7771979 |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
John Polo, Thomas W. Dubensky, Jr., Ilya Frolov, Jason Gardner, Gillis Otten +1 more |
2010-08-10 |
$13,657,000 |
| 7572628 |
Eukaryotic layered vector initiation systems |
Thomas W. Dubensky, Jr., John Polo, Carlos Ibanez, Stephen Chang, Douglas J. Jolly +1 more |
2009-08-11 |
$24,316,000 |
| 6376236 |
Recombinant alphavirus particles |
Thomas W. Dubensky, Jr., John Polo, Carlos Ibanez |
2002-04-23 |
$62,825,000 |
| 6342372 |
Eukaryotic layered vector initiation systems for production of recombinant proteins |
Thomas W. Dubensky, Jr., John Polo |
2002-01-29 |
$25,031,000 |
| 6333195 |
Crossless retroviral vectors |
James G. Respess, Nicholas J. DePolo, Sunil Chada, Sybille Sauter, Mordechai Bodner |
2001-12-25 |
|
| 6015686 |
Eukaryotic layered vector initiation systems |
Thomas W. Dubensky, Jr., John Polo, Douglas J. Jolly |
2000-01-18 |
$50,022,000 |
| 6013517 |
Crossless retroviral vectors |
James G. Respess, Nicholas J. DePolo, Sunil Chada, Sybille Sauter, Mordechai Bodner |
2000-01-11 |
$45,852,000 |
| 5843723 |
Alphavirus vector constructs |
Thomas W. Dubensky, Jr., John Polo, Carlos Ibanez, Stephen Chang, Douglas J. Jolly +1 more |
1998-12-01 |
$14,204,000 |
| 5814482 |
Eukaryotic layered vector initiation systems |
Thomas W. Dubensky, Jr., John Polo, Douglas J. Jolly |
1998-09-29 |
|
| 5789245 |
Alphavirus structural protein expression cassettes |
Thomas W. Dubensky, Jr., John Polo, Carlos Ibanez, Stephen Chang, Douglas J. Jolly |
1998-08-04 |
$8,804,000 |
